Medicus Pharma Ltd. Common Stock
MDCX
Get informed when a big investor buys or sells
+ FollowMarket Cap$138.19M
Close$
$0.27
89.1% downside
Current Fair Value
89.1% downsideOvervalued by 89.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $138.19 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.96 |
| Beta | -0.61 |
| Outstanding Shares | 55,055,225 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | -0.16 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-6.38
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-6.68
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.76%▼ 3.09% |
|---|---|
| Total Invested | $1.18M▲ 10.82% |
| Investors Holding | 22▲ 2.00% |
ESG Score
No data
About Medicus Pharma Ltd. Common Stock
16 employees
CEO: Raza Bokhari Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company ...